Anterogen Co EBIT per Share
The EBIT per Share of Anterogen Co (065660.KQ) as of Nov 2, 2026 is -243.16 KRW. In the previous year, EBIT per Share was -390.98 KRW — a change of -37.81% (higher).
Get this data via API
Financial Data API
EBIT per Share
-243.16KRW
YoY
-37.81%
Last updated:
The Anterogen Co EBIT per Share history
3 Years
10 Years
25 Years
Max
| YEAR | EBIT per Share | YoY |
|---|---|---|
| -243.16KRW | -37.81% | |
| -390.98KRW | -30.27% | |
| -560.71KRW | -12.68% | |
| -642.17KRW | +129.80% | |
| -279.45KRW | -7.33% | |
| -301.56KRW | -45.73% | |
| -555.71KRW | +88.43% | |
| -294.92KRW | +1,540.28% | |
| -17.98KRW | -230.75% | |
| 13.75KRW | -168.08% | |
| -20.20KRW | -92.10% | |
| -255.75KRW | -16.82% | |
| -307.47KRW | -405.29% | |
| 100.71KRW | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Anterogen Co Stock analysis
Frequently Asked Questions about Anterogen Co stock
EBIT per Share of Anterogen Co is -243.16 KRW in 2025.
EBIT per Share of Anterogen Co changed from -390.98 KRW to -243.16 KRW, representing a -37.81% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Anterogen Co since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Anterogen Co
All Key Metrics — Anterogen Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth